1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Genepoint Biological Technology (China) Co, Ltd

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Shanghai China

Primary Industry

Medical Devices & Equipment

About

Based in Shanghai, China and established in 2015, Genepoint Biological Technology (China) Co, Ltd is a technology company that focuses on researching and developing cryogenic biomaterial storage systems. The company's R&D center is in Chengdu. The company focuses on intelligent biological deep cryogenic storage system solutions, including automated storage for cryo-bio material, cryogenic cold chain logistics, data management and biobank turn-key project, and the cryogenic storage of hybrid energy. The automated cryogenic storage system, KIOSK, of which the operating area can be completely isolated from the storage area, and the robotic arm can directly pick the pipe at -80°C. Besides, the company also provides nitrogen preservation series, deep cryogenic transport robots, and cryogenic tube picking workstations.
Current Investors
Shanghai China Healthcare Venture Management, BMC, Tianyi Investment Group

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Medical Devices & Equipment, Logistics & Distribution, Hardware
Website
www.genepoint.cn
Verticals
Artificial Intelligence, HealthTech, Robotics
Company Stage
Series D
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.